Safety and efficacy of trifluridine/tipiracil (TAS-102) plus bevacizumab in clinical practice for patients with refractory metastatic colorectal cancer

被引：0
|
作者：
Kotani, D. [1 ]
Kuboki, Y. [1 ]
Yasuda, K. [1 ]
Nakamura, Y. [1 ]
Kawazoe, A. [1 ]
Bando, H. [1 ]
Taniguchi, H. [1 ]
Shitara, K. [1 ]
Yoshino, T. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
106P
引用
收藏
页码：34 / 34
页数：1
相关论文
共 50 条
  • [41] Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study
    Fujii, Hironori
    Matsuhashi, Nobuhisa
    Kitahora, Mika
    Takahashi, Takao
    Hirose, Chiemi
    Iihara, Hirotoshi
    Yamada, Yunami
    Watanabe, Daichi
    Ishihara, Takuma
    Suzuki, Akio
    Yoshida, Kazuhiro
    [J]. ONCOLOGIST, 2020, 25 (03): : E469 - E476
  • [42] Factors associated with efficacy of TAS-102 in patients with refractory metastatic colorectal cancer (mCRC).
    Grell, Peter
    Dvorak, Josef
    Vocka, Michal
    John, Stanislav
    Tuskova, Helena
    Buchler, Tomas
    Petruzelka, Lubos B.
    Vyzula, Rostislav
    Obermannova, Radka
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [43] Retrospective study of TAS-102 plus bevacizumab for patients with metastatic colorectal cancer in salvage therapy
    Hisamatsu, A.
    Ikusue, T.
    Toshima, H.
    Kobayashi, K.
    Shimada, K.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [44] Compassionate use program for trifluridine/tipiracil (TAS-102) in metastatic colorectal cancer: a real-life overview
    Salvatore, L.
    Niger, M.
    Bellu, L.
    Tamburini, E.
    Garcia-Alfonso, P.
    Amellal, N.
    Delmas, A-S.
    Wahba, M.
    Prager, G.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [45] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Martinez-Lago, Nieves
    Calleja Chucla, Teresa
    Alonso De Castro, Beatriz
    Varela Ponte, Rafael
    Reboredo Rendo, Cristina
    Gomez-Randulfe Rodriguez, Martin Igor
    Silva Diaz, Sofia
    Grana Suarez, Begona
    de la Camara Gomez, Juan
    Busto Fernandez, Fernando
    Mateos Salvador, Maria
    Reboredo Lopez, Margarita
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [46] Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme
    Sforza, Vincenzo
    Martinelli, Erika
    Cardone, Claudia
    Martini, Giulia
    Napolitano, Stefania
    Vitiello, Pietro Paolo
    Vitale, Pasquale
    Zanaletti, Nicoletta
    Reginelli, Alfonso
    Di Bisceglie, Maurizio
    Latiano, Tiziana Pia
    Bochicchio, Anna Maria
    Cecere, Fabiana
    Selvaggi, Francesco
    Ciardiello, Fortunato
    Troiani, Teresa
    [J]. ESMO OPEN, 2017, 2 (04)
  • [47] Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
    Nieves Martínez-Lago
    Teresa Calleja Chucla
    Beatriz Alonso De Castro
    Rafael Varela Ponte
    Cristina Reboredo Rendo
    Martin Igor Gomez-Randulfe Rodriguez
    Sofia Silva Diaz
    Begoña Graña Suarez
    Juan de la Cámara Gomez
    Fernando Busto Fernández
    María Mateos Salvador
    Margarita Reboredo Lopez
    [J]. Scientific Reports, 12
  • [48] A Comparison of Bevacizumab Plus TAS-102 and TAS-102 Monotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Xiaochen
    Qiu, Huafeng
    Chen, Yunwang
    Wang, Mingxing
    Zhu, Pengfei
    Pan, Shuangyue
    Deng, Yaya
    Yang, Liu
    Chen, Zheling
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
    Gianluca Arrichiello
    Alessandra Perrone
    Stefania Napolitano
    Giulia Martini
    Vincenzo De Falco
    Pasquale Incoronato
    Maria Maddalena Laterza
    Gaetano Facchini
    Vincenzo Famiglietti
    Valeria Nacca
    Fernando Paragliola
    Rossella Napolitano
    Gabriella Suarato
    Antonella Nicastro
    Erika Martinelli
    Davide Ciardiello
    Fortunato Ciardiello
    Teresa Troiani
    [J]. Targeted Oncology, 2022, 17 : 635 - 642
  • [50] Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal Cancer
    Arrichiello, Gianluca
    Perrone, Alessandra
    Napolitano, Stefania
    Martini, Giulia
    De Falco, Vincenzo
    Incoronato, Pasquale
    Laterza, Maria Maddalena
    Facchini, Gaetano
    Famiglietti, Vincenzo
    Nacca, Valeria
    Paragliola, Fernando
    Napolitano, Rossella
    Suarato, Gabriella
    Nicastro, Antonella
    Martinelli, Erika
    Ciardiello, Davide
    Ciardiello, Fortunato
    Troiani, Teresa
    [J]. TARGETED ONCOLOGY, 2022, 17 (06) : 635 - 642
12345